tetradecanoylphorbol acetate has been researched along with ikarugamycin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, A; Fredericksen, BL; Garcia, JV; Hasumi, K; Luo, T | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and ikarugamycin
| Article | Year |
|---|---|
Human immunodeficiency virus type 1 Nef-induced CD4 cell surface downregulation is inhibited by ikarugamycin.
Topics: Anti-Bacterial Agents; CD4 Antigens; Down-Regulation; Gene Products, nef; HIV-1; Humans; Lactams; Monocytes; nef Gene Products, Human Immunodeficiency Virus; Tetradecanoylphorbol Acetate | 2001 |